Ameritas Investment Partners, Inc. Tcr2 Therapeutics Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.11 - $2.94 $4,568 - $6,365	-2,165 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$13.1 - $20.69 $15,602 - $24,641	1,191 Added 122.28%	2,165 $44,000
Q3 2019 Nov 14, 2019	BUY	$10.15 - $19.53 $8,292 - $15,956	817 Added 520.38%	974 $15,000
Q2 2019 Aug 14, 2019	BUY	$13.64 - $20.97 $2,141 - $3,292	157 New	157 $2,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.